Deltex-1 Activates Mitotic Signaling and Proliferation and Increases the Clonogenic and Invasive Potential of U373 and LN18 Glioblastoma Cells and Correlates with Patient Survival

PLoS ONE

Volumn 8, Issue 2, 2013, Pages

  Huber, Roland M ^a,b,d   Rajski, Michal ^c   Sivasankaran, Balasubramanian ^a,e   Moncayo, Gerald ^b   Hemmings, Brian A ^b   Merlo, Adrian ^a  

^a UNIVERSITY OF BASEL   (Switzerland)

^b FRIEDRICH MIESCHER INSTITUTE FOR BIOMEDICAL RESEARCH   (Switzerland)

^c UNIVERSITY OF ZURICH   (Switzerland)

^d Fred Hutchinson Cancer Research Center   (United States)

^e EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DELTEX 1; MICRORNA 21; MITOGEN ACTIVATED PROTEIN KINASE; NOTCH RECEPTOR; UNCLASSIFIED DRUG;

ARTICLE; BREAST CANCER; CANCER PATIENT; CANCER PROGNOSIS; CANCER SURVIVAL; CELL FUNCTION; CELL GROWTH; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CELL SURVIVAL; CLONOGENESIS; COHORT ANALYSIS; CONTROLLED STUDY; ENZYME ACTIVATION; GENE EXPRESSION; GENE OVEREXPRESSION; GENETIC ANALYSIS; GLIOBLASTOMA; GLIOMA CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; MICROARRAY ANALYSIS; MITOSIS; NUCLEOTIDE SEQUENCE; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION;

BRAIN NEOPLASMS; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; CELL SURVIVAL; DNA-BINDING PROTEINS; FEMALE; GENE EXPRESSION; GLIOBLASTOMA; HUMANS; MICRORNAS; MITOSIS; NEOPLASM INVASIVENESS; RECEPTORS, NOTCH; SIGNAL TRANSDUCTION;

EID: 84874354425     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0057793     Document Type: Article

References (56)

1. Stupp R, Weber DC, (2005) The role of radio- and chemotherapy in glioblastoma. Onkologie 28: 315-317.
2. Burnet NG, Jefferies SJ, Benson RJ, Hunt DP, Treasure FP, (2005) Years of life lost (YLL) from cancer is an important measure of population burden--and should be considered when allocating research funds. Br J Cancer 92: 241-245.
3. Dotto GP, (2009) Crosstalk of Notch with p53 and p63 in cancer growth control. Nat Rev Cancer 9: 587-595.
4. Purow BW, Haque RM, Noel MW, Su Q, Burdick MJ, et al. (2005) Expression of Notch-1 and its ligands, Delta-like-1 and Jagged-1, is critical for glioma cell survival and proliferation. Cancer Res 65: 2353-2363.
5. Zhang X, Chen T, Zhang J, Mao Q, Li S, et al. (2011) Notch1 promotes glioma cell migration and invasion by stimulating beta-catenin and NF-kappaB signaling via AKT activation. Cancer Sci.
6. Wang J, Wakeman TP, Lathia JD, Hjelmeland AB, Wang XF, et al. (2010) Notch promotes radioresistance of glioma stem cells. Stem Cells 28: 17-28.
7. Gilbert CA, Daou MC, Moser RP, Ross AH, (2010) Gamma-secretase inhibitors enhance temozolomide treatment of human gliomas by inhibiting neurosphere repopulation and xenograft recurrence. Cancer Res 70: 6870-6879.
8. Fan X, Khaki L, Zhu TS, Soules ME, Talsma CE, et al. (2010) NOTCH pathway blockade depletes CD133-positive glioblastoma cells and inhibits growth of tumor neurospheres and xenografts. Stem Cells 28: 5-16.
9. Zhu TS, Costello MA, Talsma CE, Flack CG, Crowley JG, et al. (2011) Endothelial cells create a stem cell niche in glioblastoma by providing NOTCH ligands that nurture self-renewal of cancer stem-like cells. Cancer Res 71: 6061-6072.
10. Boulay JL, Miserez AR, Zweifel C, Sivasankaran B, Kana V, et al. (2007) Loss of NOTCH2 positively predicts survival in subgroups of human glial brain tumors. PLoS One 2: e576.
11. Zamecnik J, (2005) The extracellular space and matrix of gliomas. Acta Neuropathol 110: 435-442.
12. Sivasankaran B, Degen M, Ghaffari A, Hegi ME, Hamou MF, et al. (2009) Tenascin-C is a novel RBPJkappa-induced target gene for Notch signaling in gliomas. Cancer Res 69: 458-465.
13. Lino M, Merlo A, (2009) Translating biology into clinic: the case of glioblastoma. Curr Opin Cell Biol 21: 311-316.
14. Matsuno K, Diederich RJ, Go MJ, Blaumueller CM, Artavanis-Tsakonas S, (1995) Deltex acts as a positive regulator of Notch signaling through interactions with the Notch ankyrin repeats. Development 121: 2633-2644.
15. Mukherjee A, Veraksa A, Bauer A, Rosse C, Camonis J, et al. (2005) Regulation of Notch signalling by non-visual beta-arrestin. Nat Cell Biol 7: 1191-1201.
16. Liu WH, Lai MZ, (2005) Deltex regulates T-cell activation by targeted degradation of active MEKK1. Mol Cell Biol 25: 1367-1378.
17. Hu QD, Ang BT, Karsak M, Hu WP, Cui XY, et al. (2003) F3/contactin acts as a functional ligand for Notch during oligodendrocyte maturation. Cell 115: 163-175.
18. Hu QD, Cui XY, Ng YK, Xiao ZC, (2004) Axoglial interaction via the notch receptor in oligodendrocyte differentiation. Ann Acad Med Singapore 33: 581-588.
19. Eiraku M, Tohgo A, Ono K, Kaneko M, Fujishima K, et al. (2005) DNER acts as a neuron-specific Notch ligand during Bergmann glial development. Nat Neurosci 8: 873-880.
20. Sun P, Xia S, Lal B, Eberhart CG, Quinones-Hinojosa A, et al. (2009) DNER, an epigenetically modulated gene, regulates glioblastoma-derived neurosphere cell differentiation and tumor propagation. Stem Cells 27: 1473-1486.
21. Brennan K, Gardner P, (2002) Notching up another pathway. Bioessays 24: 405-410.
22. Martinez Arias A, Zecchini V, Brennan K, (2002) CSL-independent Notch signalling: a checkpoint in cell fate decisions during development? Curr Opin Genet Dev 12: 524-533.
23. Sanai N, Alvarez-Buylla A, Berger MS, (2005) Neural stem cells and the origin of gliomas. N Engl J Med 353: 811-822.
24. Yamamoto N, Yamamoto S, Inagaki F, Kawaichi M, Fukamizu A, et al. (2001) Role of Deltex-1 as a transcriptional regulator downstream of the Notch receptor. J Biol Chem 276: 45031-45040.
25. Ramain P, Khechumian K, Seugnet L, Arbogast N, Ackermann C, et al. (2001) Novel Notch alleles reveal a Deltex-dependent pathway repressing neural fate. Curr Biol 11: 1729-1738.
26. Ishii N, Maier D, Merlo A, Tada M, Sawamura Y, et al. (1999) Frequent co-alterations of TP53, p16/CDKN2A, p14ARF, PTEN tumor suppressor genes in human glioma cell lines. Brain Pathol 9: 469-479.
27. Huettner C, Paulus W, Roggendorf W, (1995) Messenger RNA expression of the immunosuppressive cytokine IL-10 in human gliomas. Am J Pathol 146: 317-322.
28. Suzuki K, Nagasawa H, Uto Y, Sugimoto Y, Noguchi K, et al. (2005) Napthalimidobenzamide DB-51630: a novel DNA binding agent inducing p300 gene expression and exerting a potent anti-cancer activity. Bioorg Med Chem 13: 4014-4021.
29. Korur S, Huber RM, Sivasankaran B, Petrich M, Morin P Jr, et al. (2009) GSK3beta regulates differentiation and growth arrest in glioblastoma. PLoS One 4: e7443.
30. Gentleman RC, Carey VJ, Bates DM, Bolstad B, Dettling M, et al. (2004) Bioconductor: open software development for computational biology and bioinformatics. Genome Biol 5: R80.
31. Wettenhall JM, Smyth GK, (2004) limmaGUI: a graphical user interface for linear modeling of microarray data. Bioinformatics 20: 3705-3706.
32. Suzuki R, Shimodaira H, (2006) Pvclust: an R package for assessing the uncertainty in hierarchical clustering. Bioinformatics 22: 1540-1542.
33. Holland EC, Celestino J, Dai C, Schaefer L, Sawaya RE, et al. (2000) Combined activation of Ras and Akt in neural progenitors induces glioblastoma formation in mice. Nature Genetics 25: 55-57.
34. Grzmil M, Hemmings BA, (2010) Deregulated signalling networks in human brain tumours. Biochim Biophys Acta 1804: 476-483.
35. Miele L, Golde T, Osborne B, (2006) Notch signaling in cancer. Curr Mol Med 6: 905-918.
36. Papagiannakopoulos T, Shapiro A, Kosik KS, (2008) MicroRNA-21 targets a network of key tumor-suppressive pathways in glioblastoma cells. Cancer Res 68: 8164-8172.
37. Rangarajan A, Weinberg RA, (2003) Opinion: Comparative biology of mouse versus human cells: modelling human cancer in mice. Nat Rev Cancer 3: 952-959.
38. Joy AM, Beaudry CE, Tran NL, Ponce FA, Holz DR, et al. (2003) Migrating glioma cells activate the PI3-K pathway and display decreased susceptibility to apoptosis. J Cell Sci 116: 4409-4417.
39. Zhang B, Gu F, She C, Guo H, Li W, et al. (2009) Reduction of Akt2 inhibits migration and invasion of glioma cells. Int J Cancer 125: 585-595.
40. Strippoli R, Benedicto I, Perez Lozano ML, Cerezo A, Lopez-Cabrera M, et al. (2008) Epithelial-to-mesenchymal transition of peritoneal mesothelial cells is regulated by an ERK/NF-kappaB/Snail1 pathway. Dis Model Mech 1: 264-274.
41. Gabriely G, Wurdinger T, Kesari S, Esau CC, Burchard J, et al. (2008) MicroRNA 21 promotes glioma invasion by targeting matrix metalloproteinase regulators. Mol Cell Biol 28: 5369-5380.
42. van de Vijver MJ, He YD, van't Veer LJ, Dai H, Hart AA, et al. (2002) A gene-expression signature as a predictor of survival in breast cancer. N Engl J Med 347: 1999-2009.
43. Stockhausen MT, Kristoffersen K, Poulsen HS, (2010) The functional role of Notch signaling in human gliomas. Neuro Oncol 12: 199-211.
44. Zhang P, Yang Y, Nolo R, Zweidler-McKay PA, Hughes DP, (2010) Regulation of NOTCH signaling by reciprocal inhibition of HES1 and Deltex 1 and its role in osteosarcoma invasiveness. Oncogene 29: 2916-2926.
45. Oishi K, Kamakura S, Isazawa Y, Yoshimatsu T, Kuida K, et al. (2004) Notch promotes survival of neural precursor cells via mechanisms distinct from those regulating neurogenesis. Dev Biol 276: 172-184.
46. Zohrabian VM, Forzani B, Chau Z, Murali R, Jhanwar-Uniyal M, (2009) Rho/ROCK and MAPK signaling pathways are involved in glioblastoma cell migration and proliferation. Anticancer Res 29: 119-123.
47. Lakka SS, Jasti SL, Gondi C, Boyd D, Chandrasekar N, et al. (2002) Downregulation of MMP-9 in ERK-mutated stable transfectants inhibits glioma invasion in vitro. Oncogene 21: 5601-5608.
48. Selcuklu SD, Donoghue MT, Spillane C, (2009) miR-21 as a key regulator of oncogenic processes. Biochem Soc Trans 37: 918-925.
49. Huang TH, Wu F, Loeb GB, Hsu R, Heidersbach A, et al. (2009) Up-regulation of miR-21 by HER2/neu signaling promotes cell invasion. J Biol Chem 284: 18515-18524.
50. Yoo AS, Greenwald I, (2005) LIN-12/Notch activation leads to microRNA-mediated down-regulation of Vav in C. elegans. Science 310: 1330-1333.
51. Patterson KI, Brummer T, O'Brien PM, Daly RJ, (2009) Dual-specificity phosphatases: critical regulators with diverse cellular targets. Biochem J 418: 475-489.
52. Mitsuuchi Y, Johnson SW, Sonoda G, Tanno S, Golemis EA, et al. (1999) Identification of a chromosome 3p14.3-21.1 gene, APPL, encoding an adaptor molecule that interacts with the oncoprotein-serine/threonine kinase AKT2. Oncogene 18: 4891-4898.
53. Ordentlich P, Lin A, Shen CP, Blaumueller C, Matsuno K, et al. (1998) Notch inhibition of E47 supports the existence of a novel signaling pathway. Mol Cell Biol 18: 2230-2239.
54. Cui XY, Hu QD, Tekaya M, Shimoda Y, Ang BT, et al. (2004) NB-3/Notch1 pathway via Deltex1 promotes neural progenitor cell differentiation into oligodendrocytes. J Biol Chem 279: 25858-25865.
55. Hsiao HW, Liu WH, Wang CJ, Lo YH, Wu YH, et al. (2009) Deltex1 is a target of the transcription factor NFAT that promotes T cell anergy. Immunity 31: 72-83.
56. Oliver TG, Grasfeder LL, Carroll AL, Kaiser C, Gillingham CL, et al. (2003) Transcriptional profiling of the Sonic hedgehog response: a critical role for N-myc in proliferation of neuronal precursors. Proc Natl Acad Sci U S A 100: 7331-7336.